[go: up one dir, main page]

May, 2000 - Google Patents

Conformationally restricted peptidomimetics

May, 2000

View PDF
Document ID
7875705547675162291
Author
May B
Publication year

External Links

Snippet

Peptidomimetic compounds are becoming increasing important as medicinal agents. This thesis describes the design and synthesis of a novel class of non-hydrolysable peptidomimetic isosteres, the tetrazole-based amide bond isosteres. These new structural …
Continue reading at ir.canterbury.ac.nz (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Rémond et al. Silicon-containing amino acids: synthetic aspects, conformational studies, and applications to bioactive peptides
US5672681A (en) Conformationally restricted mimetics of gamma turns and peptides containing the same
Johansson et al. Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals
AU679460B2 (en) Conformationally restricted mimetics of reverse turns and peptides containing the same
Iizuka et al. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction
Zabrocki et al. Conformational mimicry. 1. 1, 5-Disubstituted tetrazole ring as a surrogate for the cis amide bond
Wipf Synthetic studies of biologically active marine cyclopeptides
Kuranaga et al. Total synthesis and complete structural assignment of yaku’amide A
David et al. Intramolecular Staudinger ligation: a powerful ring-closure method to form medium-sized lactams
Venkatesan et al. Synthesis and enzyme inhibitory activities of novel peptide isosteres
Valentekovich et al. Enantiospecific total synthesis of the protein phosphatase inhibitor motuporin.
EP0573608A1 (en) Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
Fukuzumi et al. Chemoselective cyclization of unprotected linear peptides by α-ketoacid–hydroxylamine amide-ligation
Eguchi et al. Design, synthesis, and application of peptide secondary structure mimetics
TW200800889A (en) Processes and intermediates
Hattori et al. Synthesis of silacyclic dipeptides: peptide elongation at both N-and C-termini of dipeptide
Stefanucci et al. Conformationally constrained histidines in the design of peptidomimetics: strategies for the χ-space control
US20050267017A1 (en) Conformationally constrained C-backbone cyclic peptides
Romero-Estudillo et al. Domino process achieves site-selective peptide modification with high optical purity. Applications to chain diversification and peptide ligation
Kurasaki et al. Isostearyl Mixed Anhydrides for the Preparation of N-Methylated Peptides Using C-Terminally Unprotected N-Methylamino Acids
IE62614B1 (en) Methods and compositions for preparing of h-arg-x-z-y-tyr-r
Zarezin et al. Diazocarbonyl derivatives of amino acids: unique chiral building blocks for the synthesis of biologically active compounds
May Conformationally restricted peptidomimetics
Ryadnov et al. Amino Acids, Peptides and Proteins: Volume 42
San Juan et al. 3D-QSAR studies on angiotensin-converting enzyme (ACE) inhibitors: a molecular design in hypertensive agents